4//SEC Filing
Petrova Penka 4
Accession 0001062993-21-001199
CIK 0001616212other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 7:18 PM ET
Size
17.3 KB
Accession
0001062993-21-001199
Insider Transaction Report
Form 4
Petrova Penka
Chief Development Officer
Transactions
- Exercise/Conversion
Common Shares
2021-02-08$3.31/sh+2,604$8,629→ 5,312 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-08−2,604→ 54,688 totalExercise: $3.31Exp: 2028-11-08→ Common Shares (2,604 underlying) - Exercise/Conversion
Common Shares
2021-02-08$0.30/sh+2,708$806→ 2,708 total - Sale
Common Shares
2021-02-08$12.65/sh−5,312$67,197→ 0 total - Exercise/Conversion
Common Shares
2021-02-09$9.62/sh+508$4,888→ 508 total - Sale
Common Shares
2021-02-09$14.17/sh−508$7,200→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-08−2,708→ 89,376 totalExercise: $0.30Exp: 2029-11-07→ Common Shares (2,708 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-09−508→ 4,574 totalExercise: $9.62Exp: 2027-11-09→ Common Shares (508 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
- [F3]The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
- [F4]The exercise price of these options is $12.22 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7873 USD.
- [F5]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeother
Related Parties
1- filerCIK 0001838044
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 7:18 PM ET
- Size
- 17.3 KB